How much does Genome Research Trading Limited make?

Genome Research Trading Limited reported revenue of £2.1m and £91.8k profit in the year to 30 Sep 2025, according to its accounts filed at Companies House.

How many employees does Genome Research Trading Limited have?

Genome Research Trading Limited reported an average of 0 employees in the year to 30 Sep 2025.

Is Genome Research Trading Limited profitable?

Yes — Genome Research Trading Limited reported a profit of £91.8k in the year to 30 Sep 2025.

Company No. 10058101 · Incorporated 11 Mar 2016

Genome Research Trading Limited

Registered name: GENOME RESEARCH TRADING LIMITED

Part of The Wellcome Trust Limited group

Genome Research Trading Limited made £2.1m revenue and £91.8k profit in the year to 30 Sep 2025.

Genome Research Trading Limited’s revenue fell 5% to £2.1m in the year to 30 Sep 2025, with £91.8k profit and 0 employees. The company is classified under “other professional, scientific and technical activities” and is based in London; we hold 2 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 74909Other professional, scientific and technical activities n.e.c.

Status: Active
Location: London, London
Age: 10 yrs · since 2016
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 30 Sep 2025

Key figures

Small team

Revenue

£2.1m

Growth ▼4.8%

Profit

£91.8k

Growth ▼33.7%

Profit margin

4.4%

Gross 64%

Employees

Change —

Profit / employee

—

Profitable streak

2yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Sep 2024	30 Sep 2025
Disclosure	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£2.2m	£2.1m
Cost of sales	£893k	£747k
Gross profit	£1.3m	£1.3m
Operating profit	£138k	£91.8k
Profit before tax	£138k	£91.8k
Profit after tax	£138k	£91.8k
Profit (best available)	£138k	£91.8k
Employees (average)	0	0
Ratios
Profit margin	6.3%	4.4%
Gross margin	59%	64%
Growth (year on year)
Revenue growth	—	▼4.8%
Profit growth	—	▼33.7%
Balance sheet — indirect signals, not revenue
Cash at bank	£262k	£232k
Net assets	£1	£1
Current assets	£542k	£517k
Debtors	£223k	£198k
Deferred income	£242k	£211k
Source	FullAccounts · bulk data Feb 2026	FullAccounts · bulk data Feb 2026

Derived from the latest filing

How the business works

Profit margin: 4.4%; Profit ÷ revenue.
Gross margin: 64%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 10.2%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 9.6%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: 0%; Now £1
Cash at bank: ▼11%; Now £232k
Headcount: —; Now 0
Deferred income: ▼13%; Now £211k
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

The Wellcome Trust Limitedultimate parent75–100%
Genome Research Limited75–100%
Genome Research Trading Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

GRL Construction LimitedRev. £457k · Profit £0
Base RX LimitedFigures not disclosed
Genome Research Pensions Trustee LimitedFigures not disclosed
Hinxton Hall LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Sep 2025 (profit £91.8k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.